A Retrospective Analysis of Renal Function, Tac Dose Adjustments and CYP3A5 Pharmacogenetics in Stable Renal Transplant Recipients Converted From Tac BID to Tac OD

Trial Profile

A Retrospective Analysis of Renal Function, Tac Dose Adjustments and CYP3A5 Pharmacogenetics in Stable Renal Transplant Recipients Converted From Tac BID to Tac OD

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Nov 2014

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Transplant rejection
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 18 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Feb 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
    • 13 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top